Our study thus delineates divergent metabolomes by individual UGT gene loss at the systemic level, well beyond steroidogenesis, providing potential novel insights on how UGT2B17 and UGT2B28 may differentially influence the course of PCa. The gene discussed is UGT2B28; the disease is posterior cortical atrophy.